Mo1558: REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB FOR MODERATE-SEVERE MULTI-REFRACTORY CROHN’S DISEASE: RESULTS FROM A BELGIAN MULTI-CENTRIC COHORT

Dahham Alsoud,Denis Franchimont, François D’Heygere,Peter Bossuyt, Anne Vijverman, Philippe Van Hootegem,João Sabino,Anneline Cremer,Séverine Vermeire,Marc Ferrante

Gastroenterology(2022)

引用 0|浏览0
暂无评分
关键词
crohns,risankizumab,real-world,moderate-severe,multi-refractory,multi-centric
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要